Clinical Pharmacology & Therapeutics · 2012 · 26 citations · 38 references
PharmacyPharmacologyBioavailabilityClinical PharmacologyDrug DeliveryHemodynamicsSkin Barrier FunctionVasodilator TherapyBlood FlowClinical Pharmacology EvidenceNitric OxideNitric Oxide BioavailabilityNitric Oxide-mediated VasodilationThrombocyte Disorders
Many local hemodynamic and vascular disorders may be the result of impaired bioavailability of nitric oxide (NO). Previous findings point to a therapeutic potential of dermal NO application in the treatment of hemodynamic disorders, but no reliable data are available on the mechanisms, kinetics, or biological responses relating to cutaneous exposure to NO in humans in vivo. Here we show that, owing to its excellent diffusion capacity, cutaneously applied NO rapidly penetrates the epidermal barrier in significant amounts, strongly enriching skin tissue and blood plasma with its vasoactive derivates. In parallel, it significantly increased vasodilatation and blood flow and reduced thrombocyte aggregation capacity. Data presented here for the first time show that, in humans, dermal application of NO has strong potential for use in the therapy of local hemodynamic disorders arising from insufficient availability of NO or its bioactive derivates.
38
The Standardized Normal Ivy Bleeding Time and Its Prolongation by Aspirin
C. Harold Mielke, Marc Kaneshiro, Ian A. Maher et al. · Blood · 1969 · 664 citations · Full text
Platelet-Endothelial Cell Interactions During Ischemia/Reperfusion: The Role of P-Selectin
G. Enders, Rosmarie Leiderer, Simone Eisenmenger et al. · Blood · 1998 · 352 citations
Medicine, Cell Biology, Hematology +12